Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Editor's Choice - Impact of Comorbidity, Medication, and Gender on Amputation Rate Following Revascularisation for Chronic Limb Threatening Ischaemia.

Baubeta Fridh E, Andersson M, Thuresson M, Sigvant B, Kragsterman B, Johansson S, Hasvold P, Nordanstig J, Falkenberg M.

Eur J Vasc Endovasc Surg. 2018 Nov;56(5):681-688. doi: 10.1016/j.ejvs.2018.06.003. Epub 2018 Aug 6.

PMID:
30093176
2.

International Variations in Amputation Practice: A VASCUNET Report.

Behrendt CA, Sigvant B, Szeberin Z, Beiles B, Eldrup N, Thomson IA, Venermo M, Altreuther M, Menyhei G, Nordanstig J, Clarke M, Rieß HC, Björck M, Debus ES.

Eur J Vasc Endovasc Surg. 2018 Sep;56(3):391-399. doi: 10.1016/j.ejvs.2018.04.017. Epub 2018 May 30.

PMID:
29859821
3.

International Consortium of Vascular Registries Consensus Recommendations for Peripheral Revascularisation Registry Data Collection.

Behrendt CA, Bertges D, Eldrup N, Beck AW, Mani K, Venermo M, Szeberin Z, Menyhei G, Thomson I, Heller G, Wigger P, Danielsson G, Galzerano G, Lopez C, Altreuther M, Sigvant B, Rieß HC, Sedrakyan A, Beiles B, Björck M, Boyle JR, Debus ES, Cronenwett J.

Eur J Vasc Endovasc Surg. 2018 Aug;56(2):217-237. doi: 10.1016/j.ejvs.2018.04.006. Epub 2018 May 30.

PMID:
29776646
4.

Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome.

Sartipy F, Sigvant B, Lundin F, Wahlberg E.

Eur J Vasc Endovasc Surg. 2018 Apr;55(4):529-536. doi: 10.1016/j.ejvs.2018.01.019. Epub 2018 Feb 23.

PMID:
29478910
5.

Long-term cardiovascular outcome, use of resources, and healthcare costs in patients with peripheral artery disease: results from a nationwide Swedish study.

Hasvold P, Nordanstig J, Kragsterman B, Kristensen T, Falkenberg M, Johansson S, Thuresson M, Sigvant B.

Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):10-17. doi: 10.1093/ehjqcco/qcx028.

6.

Amputation Rates, Mortality, and Pre-operative Comorbidities in Patients Revascularised for Intermittent Claudication or Critical Limb Ischaemia: A Population Based Study.

Baubeta Fridh E, Andersson M, Thuresson M, Sigvant B, Kragsterman B, Johansson S, Hasvold P, Falkenberg M, Nordanstig J.

Eur J Vasc Endovasc Surg. 2017 Oct;54(4):480-486. doi: 10.1016/j.ejvs.2017.07.005. Epub 2017 Aug 7.

7.

Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.

Sigvant B, Hasvold P, Kragsterman B, Falkenberg M, Johansson S, Thuresson M, Nordanstig J.

J Vasc Surg. 2017 Aug;66(2):507-514.e1. doi: 10.1016/j.jvs.2017.01.067. Epub 2017 Apr 19.

8.

Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.

Sigvant B, Kragsterman B, Falkenberg M, Hasvold P, Johansson S, Thuresson M, Nordanstig J.

J Vasc Surg. 2016 Oct;64(4):1009-1017.e3. doi: 10.1016/j.jvs.2016.03.429. Epub 2016 May 18.

9.

The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease.

Sigvant B, Lundin F, Wahlberg E.

Eur J Vasc Endovasc Surg. 2016 Mar;51(3):395-403. doi: 10.1016/j.ejvs.2015.10.022. Epub 2016 Jan 6. Review.

10.

[Blow out hemorrhage in the head and neck region in practice. Suggestions for what we can, may and should do].

Sjögren A, Lynøe N, Leijonhufvud M, Sigvant B.

Lakartidningen. 2014 Feb 19-25;111(8):331-3. Swedish. No abstract available.

PMID:
24669452
11.

Differences in presentation of symptoms between women and men with intermittent claudication.

Sigvant B, Lundin F, Nilsson B, Bergqvist D, Wahlberg E.

BMC Cardiovasc Disord. 2011 Jun 30;11:39. doi: 10.1186/1471-2261-11-39.

12.

Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?

Sigvant B, Henriksson M, Lundin F, Wahlberg E.

Eur J Cardiovasc Prev Rehabil. 2011 Apr;18(2):254-61. doi: 10.1177/1741826710389368. Epub 2011 Jan 28.

PMID:
21450673
13.

Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.

Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Wahlberg E.

Eur J Cardiovasc Prev Rehabil. 2009 Feb;16(1):39-46. doi: 10.1097/HJR.0b013e32831c1383.

PMID:
19237996
14.

A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences.

Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, Wahlberg E.

J Vasc Surg. 2007 Jun;45(6):1185-91.

Supplemental Content

Loading ...
Support Center